Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: What is the optimal strategy?

Elias Jabbour, Jorge E. Cortes, Hagop M. Kantarjian

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: What is the optimal strategy?'. Together they form a unique fingerprint.

Medicine & Life Sciences